Ken Griffin Orasure Technologies Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Orasure Technologies Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 2,200 shares of OSUR stock, worth $8,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,200

Previous 8,500 74.12%

Holding current value

$8,008

Previous $36,000 75.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.93 - $4.59 $117,314 - $137,016	29,851 Added 2.93%	1,050,171 $4.48 Million
Q2 2024 Aug 14, 2024	BUY	$4.2 - $6.18 $4.24 Million - $6.24 Million	1,009,719 Added 9524.75%	1,020,320 $4.35 Million
Q1 2024 May 15, 2024	SELL	$6.08 - $8.28 $16,640 - $22,662	-2,737 Reduced 20.52%	10,601 $65,000
Q4 2023 Feb 14, 2024	BUY	$5.13 - $8.35 $29,692 - $48,329	5,788 Added 76.66%	13,338 $109,000
Q3 2023 Nov 14, 2023	SELL	$4.4 - $6.91 $983,202 - $1.54 Million	-223,455 Reduced 96.73%	7,550 $44,000
Q2 2023 Aug 14, 2023	BUY	$4.88 - $7.39 $76,674 - $116,111	15,712 Added 7.3%	231,005 $1.16 Million
Q1 2023 May 15, 2023	SELL	$4.66 - $6.52 $646,150 - $904,056	-138,659 Reduced 39.17%	215,293 $1.3 Million
Q4 2022 Feb 14, 2023	SELL	$3.7 - $5.29 $546,268 - $781,015	-147,640 Reduced 29.43%	353,952 $1.71 Million
Q3 2022 Nov 14, 2022	SELL	$2.72 - $4.61 $108,590 - $184,045	-39,923 Reduced 7.37%	501,592 $1.9 Million
Q2 2022 Aug 15, 2022	BUY	$2.71 - $7.12 $1.21 Million - $3.19 Million	447,468 Added 475.79%	541,515 $1.47 Million
Q1 2022 May 16, 2022	SELL	$6.62 - $9.33 $420,648 - $592,846	-63,542 Reduced 40.32%	94,047 $637,000
Q4 2021 Feb 14, 2022	BUY	$8.3 - $11.29 $515,164 - $700,747	62,068 Added 64.98%	157,589 $1.37 Million
Q3 2021 Nov 15, 2021	SELL	$9.73 - $13.38 $238,336 - $327,743	-24,495 Reduced 20.41%	95,521 $1.08 Million
Q2 2021 Aug 16, 2021	SELL	$9.02 - $11.68 $813,811 - $1.05 Million	-90,223 Reduced 42.91%	120,016 $1.22 Million
Q1 2021 May 17, 2021	SELL	$9.53 - $15.42 $176,648 - $285,825	-18,536 Reduced 8.1%	210,239 $2.45 Million
Q4 2020 Feb 16, 2021	SELL	$10.35 - $15.94 $1.69 Million - $2.61 Million	-163,579 Reduced 41.69%	228,775 $2.42 Million
Q3 2020 Nov 16, 2020	BUY	$10.24 - $19.58 $2.37 Million - $4.53 Million	231,222 Added 143.5%	392,354 $4.78 Million
Q2 2020 Aug 14, 2020	BUY	$9.71 - $17.87 $1.35 Million - $2.48 Million	138,665 Added 617.19%	161,132 $1.87 Million
Q1 2020 May 15, 2020	SELL	$5.57 - $10.76 $866,892 - $1.67 Million	-155,636 Reduced 87.39%	22,467 $242,000
Q4 2019 Feb 14, 2020	SELL	$7.21 - $8.89 $2.84 Million - $3.5 Million	-393,370 Reduced 68.83%	178,103 $1.43 Million
Q3 2019 Nov 14, 2019	SELL	$6.57 - $9.46 $1.5 Million - $2.16 Million	-228,057 Reduced 28.52%	571,473 $4.27 Million
Q2 2019 Aug 14, 2019	BUY	$8.17 - $11.07 $4.09 Million - $5.54 Million	500,501 Added 167.38%	799,530 $7.42 Million
Q1 2019 May 15, 2019	SELL	$9.63 - $13.09 $309,537 - $420,751	-32,143 Reduced 9.71%	299,029 $0
Q4 2018 Feb 14, 2019	BUY	$10.53 - $15.54 $2.03 Million - $3 Million	192,983 Added 139.65%	331,172 $3.87 Million
Q3 2018 Nov 13, 2018	BUY	$15.25 - $17.72 $1.67 Million - $1.94 Million	109,403 Added 380.06%	138,189 $0
Q2 2018 Aug 10, 2018	SELL	$14.46 - $18.08 $933,176 - $1.17 Million	-64,535 Reduced 69.15%	28,786 $0
Q1 2018 May 11, 2018	SELL	$16.77 - $22.04 $625,521 - $822,092	-37,300 Reduced 28.56%	93,321 $1.58 Million
Q4 2017 Feb 09, 2018	BUY	$13.44 - $22.81 $1.16 Million - $1.97 Million	86,416 Added 195.49%	130,621 $2.46 Million
Q3 2017 Nov 09, 2017	BUY	$19.97 - $22.74 $882,773 - $1.01 Million	44,205	44,205 $995,000

Others Institutions Holding OSUR

# of Institutions

201

Shares Held

65.4M

Call Options Held

2.2K

Put Options Held

5.1K

View Full List

About ORASURE TECHNOLOGIES INC

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $264M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

More about OSUR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account